ESAIC 2023

Assessing the Gaps in Massive Haemorrhage

Current Approaches to Management

Saturday, June 3, 2023
13:15 - 14:15 CET

The Octapharma Euroanaesthesia Symposium addresses the current evidence and latest approaches to the treatment of major haemorrhage in cardiac surgery, trauma-induced coagulopathy (TIC) and those associated with oral anticoagulation (DOAC).

• There are several uncertainties in the management of major bleeding complications and emergency surgery in patients on DOACs. While current guidelines clearly recommend 4F-PCC over plasma for the reversal of warfarin, questions remain over the haemostatic effectiveness and thrombotic risk of 4F-PCC for FXa inhibitors. Prof. Sam Schulman discusses how to improve and standardise preoperative management in patients on antithrombotic therapy.

• Various factors may result in coagulopathy and bleeding after cardiac surgery. Prof. Jeannie Callum reviews the available laboratory tests to help determine if platelets transfusion and the use of coagulation factors will decrease the bleeding rate.

• TIC involves abnormal coagulation processes, attributable to trauma. Hypocoagulability resulting in bleeding is typically present in the early hours of TIC development, whereas later TIC is characterised by a hypercoagulable state associated with venous thromboembolism and multiple organ failure. Prof. Oliver Grottke discusses how to individualise the treatment in early TIC resuscitation.

Agenda

Meet the Speakers